The alfapump® system is not currently approved in the United States or Canada. In the United States and Canada, the alfapump® system is currently under clinical investigation (POSEIDON Study) and is being studied in adult patients with refractory or recurrent ascites due to cirrhosis. For more information regarding the POSEIDON clinical study see www.poseidonstudy.com.
The DSR therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed.
The DSR therapy is not currently approved for clinical research in the United States or Canada. There is no link between the DSR therapy and ongoing investigations with the alfapump® system in Europe.

How is the alfapump® implanted?

The alfapump® is implanted using minimally invasive surgery. This simple procedure usually takes between 30 and 60 minutes. Your physician will provide you further information on the procedure.

The extensive research and development that went into the alfapump® is reflected in the sophisticated workings of the pump mechanics and controls. The alfapump® is programmed, charged and monitored wirelessly.

While you are reading or watching television, simply place the Smart Charger over the alfapump® to charge it.

For more information about the alfapump® system, visit the alfapump® page.